In particular, and in order to advance the field, it would be important to determine whether the risk of developing hypertension is also increased in cancer patients who are not receiving antineoplastic therapy such as vascular endothelial growth factor inhibitors and tyrosine kinase inhibitors, which mediate increases in blood pressure (BP). This evidence concerns the gene VEGFA and cancer.